<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <id>https://finance.naver.com/news/news_list.naver?mode=LSS3D&amp;section_id=101&amp;section_id2=258&amp;section_id3=402</id>
    <title>네이버 금융 ─ 뉴스 ─ 기업 종목분석</title>
    <updated>2021-11-02T00:21:12.314Z</updated>
    <generator>https://github.com/jpmonette/feed</generator>
    <icon>https://finance.naver.com/news/favicon.ico</icon>
    <entry>
        <title type="html"><![CDATA[[특징주] SK바사, 노바백스 인니 긴급사용승인 소식에...8% 강세]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0003980298&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0003980298&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1"/>
        <updated>2021-11-02T00:19:12.381Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0003980298&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1" title="[특징주] SK바사, 노바백스 인니 긴급사용승인 소식에...8% 강세">[특징주] SK바사, 노바백스 인니 긴급사용승인 소식에...8% 강세</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[JLL, 한국FM대상 '스마트 오피스 부문' 대상]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004732693&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004732693&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1"/>
        <updated>2021-11-02T00:19:12.382Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004732693&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1" title="JLL, 한국FM대상 '스마트 오피스 부문' 대상">JLL, 한국FM대상 '스마트 오피스 부문' 대상</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[케이피엠테크, '가장 유력한 코로나19 치료제 중 하나'로 휴머니젠 렌질루맙 선정]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004732682&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004732682&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1"/>
        <updated>2021-11-02T00:19:12.383Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004732682&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1" title="케이피엠테크, '가장 유력한 코로나19 치료제 중 하나'로 휴머니젠 렌질루맙 선정">케이피엠테크, '가장 유력한 코로나19 치료제 중 하나'로 휴머니젠 렌질루맙 선정</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[[속보] 코스피 0.56% 코스닥 0.24% 상승 출발]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004732667&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004732667&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1"/>
        <updated>2021-11-02T00:19:12.385Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004732667&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1" title="[속보] 코스피 0.56% 코스닥 0.24% 상승 출발">[속보] 코스피 0.56% 코스닥 0.24% 상승 출발</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[진매트릭스 "코로나 백신 후보물질, 델타 변이에 100% 방어효과 확인"]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004732666&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004732666&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1"/>
        <updated>2021-11-02T00:19:12.387Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004732666&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211102&amp;page=1" title="진매트릭스 &quot;코로나 백신 후보물질, 델타 변이에 100% 방어효과 확인&quot;">진매트릭스 "코로나 백신 후보물질, 델타 변이에 100% 방어효과 확인"</a>]]></content>
    </entry>
</feed>